Skip to content
Delayed ~15 min

PRGO PERRIGO PLC

Health Care · Russell 2000

Next earnings: not announced yet

What 6 analyst firms say about PERRIGO PLC: their latest ratings, price targets and how far the stock is from them. How it works

15.85 USD+0.14 (+0.89%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+2.5%to the avg target 16.25 USD+0.40 USD
Buy 1 · Hold 3 · Sell 1

5 rated views · 6 analyst/firm records · 6 firms

Latest report29 Oct 2026avg report date 20 May
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
  • Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)

Recent analyst activity · last 90 days

Our tracked history has 3 reports on PRGO from 3 analyst firms in the last 90 days (6 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target and 1 left it unchanged.

Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.

Latest observed target change: Canaccord Genuity raised its target from $17.00 (set 6 Aug 2026) to $19.00 on 30 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusChristine DooleyHold18 Sep 2026—
Canaccord GenuitySusan K AndersonBuy6 Aug 202617.00 USD
JefferiesKeith DevasHold26 Feb 202614.00 USD
JPMorganChris SchottHold15 Dec 202518.00 USD
Weiss RatingsUnnamed analyst—6 Aug 2026—
Data feed RESEARCHResearch TeamSell29 Oct 202616.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 05:53 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.